Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity: A phase II evaluation. The Rembrandt Investigators.

Authors
Category Primary study
JournalCirculation
Year 2000
This article has no abstract
Epistemonikos ID: ae672cfef662ab03d95c48c49b15f2dda500a9b2
First added on: Apr 03, 2025